Security Type | Security Class Title | Fee Calculation Rule | Amount Registered(1) | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |||||||
Equity | Class A Common stock, $0.0001 par value per share | Rule 457(c) and 457(h) of the Securities Act of 1933 (2) | 5,300,000(3) | $6.44 | $34,132,000 | $0.00014760 | $5,037.89 | |||||||
| Total Offering Amounts | $34,132,000 | $5,037.89 | ||||||||||||
Total Fee Offsets(4) | — | |||||||||||||
| Net Fee Due | $5,037.89 | |||||||||||||
(1) | Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of Common Stock, $0.0001 par value per share (“Common Stock”), of American Oncology Network, Inc. (the “Registrant”) that become issuable under the American Oncology Network, Inc. 2023 Incentive Equity Plan (the “2023 Plan”) by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration which results in an increase in the number of the outstanding shares of Common Stock. |
(2) | Estimated in accordance with Rules 457(c) and 457(h) under the Securities Act solely for the purpose of calculating the registration fee on the basis of $6.44 per share, which is the average of the high and low prices of the Registrant’s Common Stock on , 2023, as reported on the Nasdaq Capital Market. |
(3) | Represents 5,300,000 shares of Class A Common Stock reserved for issuance pursuant to the 2023 Plan. |
(4) | The Registrant does not have any fee offsets. |
